https://orcid.org/0000-0003-4682-0867
References
- Juhasz-Boss I, Jungmann P, Radosa J, et al. Two novel classification systems for uterine fibroids and subsequent uterine reconstruction after myomectomy. Arch Gynecol Obstet. 2017;295:675–680.
- Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107.
- Elizabeth S. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372:1646–1655.
- Marinova M, Rauch M, Schild H, Strunk HM. Novel non-invasive treatment with high-intensity focused ultrasound (HIFU). Ultraschall in Med. 2016;37:46–55.
- Melody T, Laura G, Callum P, et al. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. Int J Hyperther. 2019;36:295–301.
- Peng S, Xiong Y, Li K, et al. Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol. 2012;81:3832–3838.
- Chen L, ter Haar G, Hill CR. Influence of ablated tissue on the formation of high-intensity focused ultrasound lesions. Ultrasound Med Biol. 1997;23:921–931.
- Yin N, Hu L, Xiao Z-B, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperther. 2018;34:1298–1303.
- Cun JP, Fan HJ, Zhao W, et al. Factors influencing MR changes associated with sacral injury after high-intensity focused ultrasound ablation of uterine fibroids. Int J Hyperther. 2019;36:21–28.
- Petros M, John ES. Surgical anatomy of the retroperitoneal spaces, part IV: retroperitoneal nerves. Am Surg. 2010;76:253–262.
- Dellon AL, Wright EJ, Manson PN. Chronic pelvic pain after laser prostatectomy: treatment by resection of the perineal branches of the pudendal nerve. J Reconstr Microsurg. 2014;30:547–550.
- Cardella JF, Kundu S, Miller DL, et al. Society of interventional radiology clinical practice guidelines. J VascInterv Radiol. 2009;20:5189–5191.
- Orsini LF, Salardi S, Pilu G, et al. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology. 1984;153:113–116.
- Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. Bjog: Int J Obstet Gy. 2018;125:354–364.
- Zhang XH, Zhai SH, Dong GL, et al. MRI evaluating changes of pelvic fascia after high intensity focused ultrasound ablation of uterine fibroids. Chin J Med Imaging Technol. 2017;33:1540–1544.
- Liu ZQ, Gong C, Liu YC, et al. Establishment of a scoring system for predicting the difficulty level of high-intensity focused ultrasound ablation of uterine fibroids. Int J Hyperther. 2018;34:77–86.
- Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry focused ultrasound ablation of for high-intensity uterine fibroids. Medicine (Baltimore). 2015;94:e650.
- Kim YS, Lee JW, Choi CH, et al. Uterine fibroids: correlation of T2 signal intensity with semiquantitative perfusion MR parameters in patients screened for MR-guided high intensity focused ultrasound ablation. Radiology. 2016;278:925–935.
- Duc NM, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagn Interv Radiol. 2018;24:283–291.
- Yang Z, Zhang Y, Zhang R, et al. A case-control study of high-intensity focused ultrasound combined with sonographically guided intratumoral ethanol injection in the treatment of uterine fibroids. J Ultrasound Med. 2014;33:657–665.
- Liu YC, Zhang WY, He M, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperther. 2018;35:56–61.